Liver transplantation for alcoholic liver disease: selection and outcome.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 15562571)

Published in Clin Liver Dis on August 01, 1997

Authors

J R Maldonado1, E B Keeffe

Author Affiliations

1: Stanford University School of Medicine, Stanford, California, USA.

Articles by these authors

(truncated to the top 100)

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood (2001) 2.26

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

Detection and surveillance of colorectal cancer. JAMA (1989) 2.07

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther (2006) 2.04

Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. J Lab Clin Med (1979) 1.86

Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther (2004) 1.68

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67

Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol (1993) 1.64

Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology (1992) 1.58

Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl (2001) 1.55

Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis (2001) 1.54

Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53

Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg (1998) 1.53

Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest (1998) 1.52

Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol (1999) 1.50

A model for a managed care education approach to increase hepatitis awareness: Part I. Manag Care Interface (2000) 1.39

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25

Current treatment strategies for chronic hepatitis B and C. Annu Rev Med (2001) 1.23

Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant (2009) 1.11

Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology (1996) 1.11

Transjugular liver biopsy. Hepatology (1992) 1.11

Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10

Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg (1999) 1.08

Management of biliary complications after liver transplantation. Am J Surg (1992) 1.08

Management of gallstones and their complications. Am Fam Physician (2000) 1.07

Re-treatment of chronic hepatitis C with consensus interferon . Hepatology (1998) 1.05

Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther (2009) 1.04

Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy. West J Med (1974) 1.04

Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease. Chest (1994) 1.03

Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg (1999) 1.03

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. J Viral Hepat (2009) 1.01

Diagnosis and treatment of chronic hepatitis B: 2009 update. Minerva Gastroenterol Dietol (2009) 1.00

Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther (2011) 0.99

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. Aliment Pharmacol Ther (2008) 0.98

Liver transplantation for treatment of giant hepatocellular adenomas. Liver Transpl Surg (1995) 0.97

Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol (2001) 0.97

Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel. J Clin Gastroenterol (1987) 0.96

Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther (2008) 0.96

Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med (1986) 0.94

Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia. Am J Gastroenterol (1998) 0.94

Esophageal burn and the microwave oven. Ann Intern Med (1982) 0.94

Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. Gastroenterology (1982) 0.94

Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg (1996) 0.93

Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther (2004) 0.93

Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med (1993) 0.92

Liver transplantation--challenges for the future. West J Med (1991) 0.92

Disulfiram hypersensitivity hepatitis. JAMA (1974) 0.91

Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl (2001) 0.91

Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood. West J Med (1986) 0.90

Clinical approach to viral hepatitis in homosexual men. Med Clin North Am (1986) 0.90

Gastrointestinal symptoms of marathon runners. West J Med (1984) 0.90

Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation (1994) 0.90

Liver transplantation in Asian patients with chronic hepatitis B. Hepatology (1997) 0.89

Diabetic gastroparesis. Dig Dis (1996) 0.89

Hepatitis G virus: is it a hepatitis virus? West J Med (1997) 0.88

A novel technique for endoscopic removal of expandable biliary Wallstent. Gastrointest Endosc (1999) 0.88

An appraisal of patients' reactions to "informed consent" for peroral endoscopy. Gastrointest Endosc (1977) 0.88

Acute pancreatitis associated with acute hepatitis A. Am J Gastroenterol (1992) 0.87

Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol (2001) 0.87

Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Arch Surg (1994) 0.87

Liver transplantation: evolving patient selection criteria. Can J Gastroenterol (2001) 0.87

Cost-effective evaluation of acute viral hepatitis. West J Med (2000) 0.86

Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol (1999) 0.86

Isolation of a rat liver plasma membrane fraction of probable canalicular origin. Preparative technique, enzymatic profile, composition, and solute transport. Biochim Biophys Acta (1981) 0.86

Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Dig Dis Sci (1982) 0.86

Clinical outcome after percutaneous transhepatic obliteration of esophageal varices. Gastroenterology (1983) 0.86

Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference. J Gastroenterol Hepatol (1999) 0.86

Primary sclerosing cholangitis and Hodgkin's disease. Hepatology (1993) 0.86

Hepatitis B vaccination of patients with chronic liver disease. Liver Transpl Surg (1998) 0.85

Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. Gastroenterology (1980) 0.85

Acute appendicitis secondary to metastatic cholangiocarcinoma. Am J Gastroenterol (1993) 0.84

Diagnosis and treatment of primary biliary cirrhosis. Med Sci Monit (2001) 0.84

Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg (1999) 0.84

Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance. Int J Clin Pract (2012) 0.84

Prolonged cholestasis due to trimethoprim sulfamethoxazole. Gastroenterology (1992) 0.84

Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Hepatology (2001) 0.83

Initial two-year results of the Oregon Liver Transplantation Program. Am J Surg (1991) 0.83

Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation. World J Surg (1995) 0.83

Helicobacter pylori infection and blood group antigens: lack of clinical association. Am J Gastroenterol (1996) 0.83

Endoscopic gastrointestinal manifestations of liver disease. Gastrointest Endosc Clin N Am (2001) 0.83

Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg (1995) 0.82

Outcome of liver transplantation in patients with hemochromatosis. Hepatology (1994) 0.82

Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci (1994) 0.81

Primary liver transplantation without transfusion of red blood cells. Surgery (1996) 0.81

Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? J Gastroenterol Hepatol (1999) 0.81

In vitro effect of bile salts on rat liver plasma membrane, lipid fluidity, and ATPase activity. Hepatology (1981) 0.81

Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance. Int J STD AIDS (2008) 0.81

Colonoscopy preps: what's best? Gastrointest Endosc (1996) 0.81

Severe and prolonged oral contraceptive jaundice. J Clin Gastroenterol (1984) 0.81

Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. J Hepatol (1995) 0.80

Sedation and analgesia for endoscopy. Gastroenterology (1995) 0.80

Hepatitis C virus and liver transplantation. Clin Liver Dis (2001) 0.80

Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am (1995) 0.79

Aortoduodenal fistula: complication of renal artery bypass graft. Gastroenterology (1974) 0.79

Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. J Viral Hepat (2011) 0.79

Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group. Am J Gastroenterol (1999) 0.79

Liver biopsy in chronic hepatitis C: routine or selective. Am J Gastroenterol (2001) 0.79

Aortic valve endocarditis after orthotopic liver transplantation. Transplantation (1994) 0.78

Ileal volvulus following colonoscopy. Gastrointest Endosc (1985) 0.78

Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther (2007) 0.78